In conclusion, these findings underscore the multifaceted role of RIP1 in metabolism, inflammation, and cell death regulation, highlighting its potential as a therapeutic target for mitigating metabolic disorders related to obesity. Here, RIPK1 is linked to obesity due to melanocortin 4 receptor deficiency.